title: Successful treatment of combined proliferative and membranous lupus nephritis using a full corticosteroid-free regimen.
authors.affiliation: Department of Internal Medicine, French reference centre for Systemic Lupus Erythematosus, AP-HP, Hôpital Pitié-Salpêtrière, , Paris, France.
authors.forename: Bruno
authors.initials: B
authors.lastname: Tedeschi
authors.forename: Laurent
authors.initials: L
authors.lastname: Arnaud
authors.forename: Miguel
authors.initials: M
authors.lastname: Hie
authors.forename: Alexis
authors.initials: A
authors.lastname: Mathian
authors.forename: Zahir
authors.initials: Z
authors.lastname: Amoura
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000188:drug therapy*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012163:Retinal Detachment / Q000139:chemically induced; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D000069283:Rituximab; D003520:Cyclophosphamide; D009173:Mycophenolic Acid
keywords: Corticosteroids; Lupus Nephritis; Systemic Lupus Erythematosus; Treatment